Institute for Experimental Ophthalmology, School of Medicine, Westfalian-Wilhelms-University Münster, Münster, Germany.
Invest Ophthalmol Vis Sci. 2012 Dec 17;53(13):8265-79. doi: 10.1167/iovs.12-10334.
Crystallin β-b2 (crybb2) is known to support the regeneration of retinal ganglion cell (RGC) axons in culture. We investigated whether neuronal progenitor cells (NPCs) overexpressing crybb2 (crybb2-NPC) affect secondary retinal degeneration due to optic nerve crush in vivo.
NPCS were produced by dissociation and propagation of rat embryonic neural tube and eye primordial cells at embryonic days 13.5 and 15. Retinal degeneration was induced by injured optic nerve crush (BY suture, 20 seconds). Several groups were built: crybb2-NPC were injected into the vitreous body, while the Controls were comprised of recombinant crybb2-injected and PBS-injected groups. The eyes, in particular the retina, were analyzed by immunohistochemistry and Western blotting for different antigens at 2 and 4 weeks after surgery.
At 2 and 4 weeks post surgery, crybb2-NPC resided within the vitreoretinal compartment, and were persistently nestin-positive throughout the experimental period. The cells stained positive for various neurotrophins and acted as "living" cell factories to support the survival of injured RGCs. The crybb2-NPC migrated throughout the eye structures and sometimes became integrated within the tissue. Most of the ocular cells responded to the appearance of crybb2-NPC with marked changes of certain proteins, including Iba-1 (microglia), vimentin (glial cells), and rhodopsin (photoreceptors). Photoreceptors also displayed a better survival after crybb2-NPC injection compared to control groups.
Crybb2-NPC exert beneficial effects on the vitreoretinal compartment, which suggests that modified crybb2-NPC could be used in a novel strategy for the treatment of degenerative vitreoretinal diseases. However, future studies must determine the safety of in vivo administration of crybb2-NPC.
晶体蛋白β-b2(crybb2)已知可支持体外培养的视网膜神经节细胞(RGC)轴突再生。我们研究了过表达 crybb2 的神经元祖细胞(NPCs)是否会影响视神经挤压引起的体内次级视网膜变性。
NPCs 通过分离和传代培养大鼠胚胎神经管和眼原基细胞于胚胎第 13.5 天和第 15 天获得。通过损伤视神经挤压(BY 缝线,20 秒)诱导视网膜变性。建立了几个实验组:crybb2-NPC 被注射到玻璃体中,而对照组则包括重组 crybb2 注射组和 PBS 注射组。在手术后 2 周和 4 周时,通过免疫组织化学和 Western blot 分析不同抗原的眼睛,特别是视网膜。
在手术后 2 周和 4 周时,crybb2-NPC 位于玻璃体内,整个实验期间始终呈巢蛋白阳性。这些细胞对各种神经营养因子呈阳性反应,并作为“活”细胞工厂,支持受伤 RGC 的存活。crybb2-NPC 迁移到整个眼部结构中,有时会整合到组织中。大多数眼部细胞对 crybb2-NPC 的出现做出了明显的反应,某些蛋白发生了显著变化,包括 Iba-1(小胶质细胞)、波形蛋白(神经胶质细胞)和视紫红质(感光细胞)。与对照组相比,注射 crybb2-NPC 后感光细胞的存活也更好。
crybb2-NPC 对玻璃体内发挥有益作用,这表明修饰后的 crybb2-NPC 可用于治疗退行性玻璃体内视网膜疾病的新策略。然而,未来的研究必须确定 crybb2-NPC 在体内给药的安全性。